Bristol-Myers Squibb (BMY) stock forecast for 2023

The forecast has been updated: December 1, 2021 5:52


Bristol-Myers stock price online today

Analyst Target Price

72.84

Dividend Date

01.11.2021

Ex Dividend Date

30.09.2021

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Bristol-Myers stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Bristol-Myers stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $72.84 target price for Bristol-Myers stock stock.

Today 200 Day Moving Average is the resistance level (63.4 $).

50 Day Moving Average is the support level (58.56 $).




BMY Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 59.26 58.51 60.37 3.08 %
Feb 57.80 56.72 59.39 4.50 %
Mar 59.86 58.65 61.08 3.99 %
Apr 58.22 56.62 59.31 4.54 %
May 60.04 58.00 61.33 5.44 %
Jun 60.04 57.83 62.06 6.81 %
Jul 58.99 56.88 59.70 4.73 %
Aug 58.73 56.85 60.37 5.83 %
Sep 56.76 54.79 57.79 5.19 %
Oct 57.66 57.00 58.68 2.86 %
Nov 55.00 53.67 56.51 5.03 %
Dec 56.69 55.23 59.19 6.69 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Bristol-Myers stock.


Bristol-Myers overview

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization

121 281 135 000 $

EBITDA

19 712 000 000

PE Ratio

None

PEG Ratio

10.87

Dividend Per Share

1.96

Dividend Yield

0.0347

EPS

-2.42

Quarterly Earnings Growth YOY

-0.159

Quarterly Revenue Growth YOY

0.103

Trailing PE

-

Forward PE

7.07

EV To Revenue

3.42

EV To EBITDA

19.55

52 Week High

69.19

52 Week Low

53.23

50 Day Moving Average

58.56

200 Day Moving Average

63.4

Shares Outstanding

2219640000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Bristol-Myers stock forecast for this year


Bristol-Myers stock forecast for Jan 2023.
Estimated Average Forecasted Bristol-Myers Price: 59.26. Positive monthly dynamics of the instrument is expected with 3.078% volatility is expected.

Pessimistic forecast: 58.51

Optimistic: 60.37


Bristol-Myers stock forecast for Feb 2023.
Estimated Average Forecasted Bristol-Myers Price: 57.80. Negative monthly dynamics of the instrument is expected with 4.496% volatility is expected.

Pessimistic forecast: 56.72

Optimistic: 59.39


Bristol-Myers stock forecast for Mar 2023.
Estimated Average Forecasted Bristol-Myers Price: 59.86. Positive monthly dynamics of the instrument is expected with 3.989% volatility is expected.

Pessimistic forecast: 58.65

Optimistic: 61.08


Bristol-Myers stock forecast for Apr 2023.
Estimated Average Forecasted Bristol-Myers Price: 58.22. Negative monthly dynamics of the instrument is expected with 4.535% volatility is expected.

Pessimistic forecast: 56.62

Optimistic: 59.31


Bristol-Myers stock forecast for May 2023.
Estimated Average Forecasted Bristol-Myers Price: 60.04. Positive monthly dynamics of the instrument is expected with 5.438% volatility is expected.

Pessimistic forecast: 58.00

Optimistic: 61.33


Bristol-Myers stock forecast for Jun 2023.
Estimated Average Forecasted Bristol-Myers Price: 60.04. Negative monthly dynamics of the instrument is expected with 6.811% volatility is expected.

Pessimistic forecast: 57.83

Optimistic: 62.06


Bristol-Myers stock forecast for Jul 2023.
Estimated Average Forecasted Bristol-Myers Price: 58.99. Negative monthly dynamics of the instrument is expected with 4.728% volatility is expected.

Pessimistic forecast: 56.88

Optimistic: 59.70


Bristol-Myers stock forecast for Aug 2023.
Estimated Average Forecasted Bristol-Myers Price: 58.73. Negative monthly dynamics of the instrument is expected with 5.831% volatility is expected.

Pessimistic forecast: 56.85

Optimistic: 60.37


Bristol-Myers stock forecast for Sep 2023.
Estimated Average Forecasted Bristol-Myers Price: 56.76. Negative monthly dynamics of the instrument is expected with 5.186% volatility is expected.

Pessimistic forecast: 54.79

Optimistic: 57.79


Bristol-Myers stock forecast for Oct 2023.
Estimated Average Forecasted Bristol-Myers Price: 57.66. Positive monthly dynamics of the instrument is expected with 2.865% volatility is expected.

Pessimistic forecast: 57.00

Optimistic: 58.68


Bristol-Myers stock forecast for Nov 2023.
Estimated Average Forecasted Bristol-Myers Price: 55.00. Negative monthly dynamics of the instrument is expected with 5.032% volatility is expected.

Pessimistic forecast: 53.67

Optimistic: 56.51


Bristol-Myers stock forecast for Dec 2023.
Estimated Average Forecasted Bristol-Myers Price: 56.69. Positive monthly dynamics of the instrument is expected with 6.691% volatility is expected.

Pessimistic forecast: 55.23

Optimistic: 59.19



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 130.27 (03.12.2021) 1.47 %
AbbVie Inc.
ABBV 118.85 (03.12.2021) 1.69 %
Aeterna Zentaris Inc.
AEZS 0.4 (03.12.2021) -7.21 %
Allakos Inc.
ALLK 74.02 (03.12.2021) -3.10 %
Allogene Therapeutics, Inc.
ALLO 17.62 (03.12.2021) -7.70 %
Amgen Inc.
AMGN 202.44 (03.12.2021) 0.63 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17.09 (03.12.2021) -5.11 %
Aurora Cannabis Inc.
ACB 5.82 (03.12.2021) -5.21 %
Becton Dickinson and Company
BDX 244.12 (03.12.2021) 0.90 %
Biogen Inc.
BIIB 223.92 (03.12.2021) -2.01 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 103.56 (03.12.2021) -5.24 %
BioNTech SE
BNTX 344.06 (03.12.2021) 3.17 %
bluebird bio, Inc.
BLUE 9.95 (03.12.2021) -6.40 %
Boston Scientific Corp.
BSX 39.46 (03.12.2021) -0.35 %
Bristol-Myers Squibb Company
BMY 56.32 (03.12.2021) 1.64 %
Canopy Growth Corp.
CGC 9.99 (03.12.2021) -3.57 %
Castle Biosciences, Inc.
CSTL 41.43 (03.12.2021) -1.17 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 245.58 (03.12.2021) -0.93 %
Emergent BioSolutions Inc.
EBS 41.89 (03.12.2021) -1.94 %
Exelixis, Inc.
EXEL 15.84 (03.12.2021) -3.88 %
G1 Therapeutics, Inc.
GTHX 10.65 (03.12.2021) -11.69 %
Gilead Sciences, Inc.
GILD 69.56 (03.12.2021) -0.16 %
GlaxoSmithKline plc
GSK 41.25 (03.12.2021) -0.53 %
GoodRx Holdings, Inc.
GDRX 38.42 (03.12.2021) -3.13 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.78 (03.12.2021) -1.28 %
Inovio Pharmaceuticals, Inc.
INO 6.17 (03.12.2021) -6.66 %
Johnson & Johnson
JNJ 159.38 (03.12.2021) 1.46 %
Medtronic plc.
MDT 106.87 (03.12.2021) -0.38 %
Merck & Co., Inc.
MRK 73.34 (03.12.2021) -0.74 %
Moderna, Inc.
MRNA 306.72 (03.12.2021) 1.73 %
Novartis AG
NVS 80 (03.12.2021) 0.06 %
Novavax, Inc.
NVAX 160.48 (03.12.2021) -0.92 %
ObsEva SA
OBSV 2.02 (03.12.2021) -4.27 %
OrganiGram Holdings Inc.
OGI 1.82 (03.12.2021) -6.67 %
Pfizer Inc.
PFE 54.27 (03.12.2021) 2.32 %
Regeneron Pharmaceuticals, Inc.
REGN 635.16 (03.12.2021) 0.18 %
Sanofi
SNY 47.07 (03.12.2021) -1.30 %
Schrodinger, Inc.
SDGR 36.33 (03.12.2021) -4.97 %
Senseonics Holdings, Inc.
SENS 2.69 (03.12.2021) -5.94 %
Sorrento Therapeutics, Inc.
SRNE 4.945 (03.12.2021) -10.25 %
Stryker Corp.
SYK 246.87 (03.12.2021) -0.21 %
Sundial Growers Inc.
SNDL 0.564 (03.12.2021) -4.73 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.05 (03.12.2021) -1.35 %
Thermo Fisher Scientific Inc.
TMO 636.11 (03.12.2021) 1.36 %
Tilray, Inc.
TLRY 8.95 (03.12.2021) -6.18 %
UnitedHealth Group, Inc.
UNH 449.32 (03.12.2021) 0.74 %
Veeva Systems Inc.
VEEV 249.49 (03.12.2021) -4.92 %
Zomedica Corp.
ZOM 0.33 (03.12.2021) -13.16 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.19 (03.12.2021) -4.49 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.